Factor IX - Emisphere
Latest Information Update: 09 May 2011
At a glance
- Originator Emisphere Technologies
- Class Antihaemorrhagics; Blood coagulation factors
- Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Haemophilia
Most Recent Events
- 20 Feb 1997 New profile
- 20 Feb 1997 Suspended-Unspecified Phase in Haemophilia in USA (PO)